News

Medical affairs teams produce evidence-based, non-promotional scientific content for healthcare professionals (HCPs), while ...
The pharma organisation prides itself on having ... Astellas’ head of regulatory affairs. “We have a pipeline of novel therapeutics and technological approaches, advancing a diverse array ...
Telangana: Natco Pharma has announced the superannuation of Dr Ramesh Dandala, Executive Vice President - Technology Transfer ...
OncoZenge AB (publ) ("OncoZenge" or "the Company") today announces the reinforcement of its Phase 3 sponsor team for BupiZenge™ to manage regulatory affairs ... brings over 20 years of experience in ...
Medical affairs can no longer afford to operate within legacy structures. Enter AI-enabled functional service provider (FSP) models that offer operational relief.
Looking ahead, this article highlights the key trends expected to shape the regulatory landscape of pharmaceutical manufacturing in 2025. Regulatory agencies—including the U.S. Food and Drug ...
Milestone Pharmaceuticals' stock fell 50% after the FDA's CRL for CMC issues, but the drug Etripamil has shown efficacy and ...
Investing in AI tools for predictive analytics will be crucial in shaping the next phase of drug safety measures ...
This blog delves into the rise of rare disease drug approvals and the critical importance of regulatory guidance in shaping ...
Indian pharma prioritizes skilled workforce proficient in techy & regulatory compliance to meet evolving market needs: Nandita Vijayasimha, Bengaluru Tuesday, April 1, 2025, 08:00 ...
This brief covers significant developments in health, including FTC's hold on an insulin lawsuit, Hungary's outbreak control ...